Results 171 to 180 of about 84,070 (269)

A Recurrent Neural Network Model for Predicting Activated Partial Thromboplastin Time After Treatment With Heparin: Retrospective Study. [PDF]

JMIR Med Inform, 2022
Boie SD, Engelhardt LJ, Coenen N, Giesa N, Rubarth K, Menk M, Balzer F.   +6 more
europepmc   +1 more source

Endovascular Stent‐Graft Exclusion for the Treatment of Haemoptysis Caused by Central Pulmonary Artery Pseudoaneurysm: A Case Report

Respirology Case Reports, Volume 14, Issue 8, August 2026.
Emergency stent‐graft exclusion effectively cured life‐threatening haemoptysis from central pulmonary artery pseudoaneurysm refractory to conventional therapy, with sustained haemostasis during 1‐year follow‐up, supporting this minimally invasive strategy as a definitive treatment option.
Dongjun Su, Shuangxi Li, Fenqiang Li
wiley   +1 more source

A Case of Severe Prekallikrein Deficiency Manifesting as Isolated Activated Partial Thromboplastin Time (aPTT) Prolongation. [PDF]

Cureus
Viswanathan D, Sivanandam A, Yeung V.
europepmc   +1 more source

Anti-Factor Xa Assay Is a Superior Correlate of Heparin Dose Than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation*

Pediatric Critical Care Medicine, 2014
Anna Liveris, R. Bello, P. Friedmann, Melissa A. Duffy, D. Manwani, J. Killinger, D. Rodriquez, S. Weinstein   +7 more
semanticscholar   +1 more source

RNA‐DNA Fusomer Fibers With Customizable Physicochemical, Mechanical, and Biological Properties for Next‐Generation Therapeutics

Small, Volume 22, Issue 44, 7 August 2026.
ABSTRACT We introduce RNA‐DNA fusomers, a new class of chemically synthesized oligonucleotides that combine the versatile properties of RNA and DNA within a single sequence and self‐assemble into higher‐order functional structures via a simple one‐pot annealing reaction.
Yasmine Radwan, Laura P. Rebolledo, Yelixza I. Avila, Elizabeth Skelly, Lauren Rackley, Julio Navas Hernandez, Renata de Freitas Saito, Laxmi K. Pandey, Hemani Chhabra, Alexander J. Lushnikov, Tatiane Katsue Furuya, Ana Luiza Lomba, Da Shi, Edward Cedrone, Ian Marriott, Morgan R. Chandler, Meni Wanunu, Aleksei Aksimentiev, Alexey V. Krasnoslobodtsev, Roger Chammas, Marina A. Dobrovolskaia, Kirill A. Afonin   +21 more
wiley   +1 more source

Algorithm-based effective recognition of acquired hemophilia A and other causes of isolated prolonged activated partial thromboplastin time within large blood sample series. [PDF]

Res Pract Thromb Haemost
Turincev P, Gomez F, Coutaz C, Quarroz S, Alberio L, Rufer N.   +5 more
europepmc   +1 more source

Survival benefit and safety evaluation of probiotic supplementation in omicron‐infected patients: Real‐world evidence from a multicenter 12,615‐patient cohort

VIEW, Volume 7, Issue 4, August 2026.
Probiotic supplements have shown benefits in reducing all‐cause mortality among hospitalized patients with SARS‐CoV‐2 infection. Patients with severe illness or without antiviral treatment were more likely to use probiotic supplements. Probiotic supplements may be a promising adjunctive therapy for SARS‐CoV‐2 infection.
Mengzhao Yang, Shanshuo Liu, Junyi Sun, Fuwei Wang, Guangyun Zhu, Xinjun Hu, Guowu Qian, Yiqiang Yuan, Hong Luo, Shixi Zhang, Guangming Li, Donghua Zhang, Guotao Li, Zujiang Yu, Zhigang Ren   +14 more
wiley   +1 more source

Dynamic changes of activated partial thromboplastin time and correlation with mortality in patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study. [PDF]

PLoS Negl Trop Dis
Wang H, Fang S, Wang H, Zheng X.
europepmc   +1 more source

Haemostatic changes and bleeding with anti‐IL‐6 directed therapy in autoimmune diseases

British Journal of Pharmacology, Volume 183, Issue 15, Page 4111-4125, August 2026.
Abstract Anti‐IL‐6 directed therapy, especially tocilizumab (TCZ), is widely used for the treatment of autoimmune diseases such as rheumatoid arthritis, giant cell arteritis and systemic juvenile idiopathic arthritis. Next to being a master regulator of inflammation, IL‐6 also is an important regulator of haemostasis. Although generally well tolerated,
Charlotte D. C. C. van der Heijden, Loes C. Oskam, Lenny van Bon, Chantal P. Rovers   +3 more
wiley   +1 more source

Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study. [PDF]

Kidney Med
Wang LS, Ertmann E, Feldman E, Kossoff M, Lu B, Lin JC, Pishko A, Redfield R, Leonberg-Yoo A, Cuker A.   +9 more
europepmc   +1 more source